{"name":"LaunXP Biomedical Co., Ltd.","slug":"launxp-biomedical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNRFJkZUJQLXVYVjQxQ3k3MUVyakctSHlVVFRTUDh0RTdaM1VIXzl2Nk1CWXptNl8ydWJkNDB6U05EemVoMlVNNzFSeUptSnRmdldYYnl1b182Y2QxYnQtRWlKaXV5UVVzQTg0SnItZ19ZU0FXN3A4OE41SHlyRUE0Sm9ya01US1RfVm1INWlsVzl0M3lwQ2dKZVVCTGpjdlF5bVdEdVM0UmZIUmVnNzN6NjVBNFlYTjNpbF9JSVBnMnJJZWJCSzNhTDdCUURGbTdNU0xoa2JsNFJHUzAwOXdSOHZRT21pbHoyLXE1UzdmeEFwUGxTWVROZXJrYjB5QQ?oc=5","date":"2025-10-14","type":"pipeline","source":"Quiver Quantitative","summary":"Apollomics Inc. Provides Operational Update and Reaffirms Commitment to APL-101 Development Following Leadership Changes and New Funding - Quiver Quantitative","headline":"Apollomics Inc. Provides Operational Update and Reaffirms Commitment to APL-101 Development Following Leadership Changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPRkZLemZ5dUNkb05BVTloNjFwaDkyZmZpQk9oNHI1M3p1eE1HdGxjMjNUMU5vQ2VacWtLTk5xdU9pclNma05UTjZGbXdScFdtSDM3TVJvNTJyaEpRbU80MzE2ZUNMS0dLdnRNcTVOX3RkMFFJRVZHNXI0RVo1STJ6TF9lanMydWhjbmpSZjhnbEprYWEyaURQbWthZ05nd0M5N1hxaGd2b3Byd2hxaTRqLW1iNDM?oc=5","date":"2025-04-02","type":"deal","source":"BioSpectrum Asia","summary":"Apollomics and LaunXP ink $50 M deal for NSCLC treatment in Asia - BioSpectrum Asia","headline":"Apollomics and LaunXP ink $50 M deal for NSCLC treatment in Asia","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}